Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 9:18 PM UTC
| NCT Number | NCT05660395 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 56 participants |
| Active Locations | 1 sites in the US |
| Sponsor | ADC Therapeutics S.A. |
| Last Updated on CT.gov | July 16, 2025 (Jul 16, 2025) |
As of July 16, 2026: Clinical trial NCT05660395 is currently recruiting participants. This phase1 study for diffuse large b-cell lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by ADC Therapeutics S.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05660395 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05660395 was last updated Jul 16, 2025 (July 16, 2025). HelloStudys verifies this status automatically.